REPROS THERAPEUTICS INC. Research and Development Expense
REPROS THERAPEUTICS INC. reported Research and Development Expense of $979.00 thousand for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-11-13.
Discontinued › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2017-11-13
- REPROS THERAPEUTICS INC. research and development expense for the quarter ending 2017-09-30 was $979.00K, a 69.23% decline year-over-year.
- REPROS THERAPEUTICS INC. research and development expense for the quarter ending 2017-06-30 was $1.14M, a 64.85% decline year-over-year.
- REPROS THERAPEUTICS INC. research and development expense for the quarter ending 2017-03-31 was $2.07M, a 44.91% decline year-over-year.
- REPROS THERAPEUTICS INC. research and development expense for the quarter ending 2016-12-31 was $2.56M, a 47.03% decline year-over-year.
- REPROS THERAPEUTICS INC. research and development expense for fiscal 2016 was $12.75M, a 47.12% decline from fiscal 2015.
- REPROS THERAPEUTICS INC. research and development expense for fiscal 2015 was $24.12M, a 11.03% decline from fiscal 2014.
- REPROS THERAPEUTICS INC. research and development expense for fiscal 2014 was $27.11M, a 14.58% increase from fiscal 2013.
- REPROS THERAPEUTICS INC. research and development expense for fiscal 2013 was $23.66M, a 67.54% increase from fiscal 2012.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed | Research and Development Expense 286 month | Research and Development Expense 289 month | Research and Development Expense 292 month | Research and Development Expense 295 month | Research and Development Expense 298 month | Research and Development Expense 301 month | Research and Development Expense 304 month | Research and Development Expense 307 month | Research and Development Expense 310 month | Research and Development Expense 313 month | Research and Development Expense 316 month | Research and Development Expense 319 month | Research and Development Expense 322 month | Research and Development Expense 325 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017-09-30 | $979.00K 10-Q · filed 2017-11-13 | $2.12M derived: sum of 2 quarters · filed 2017-11-13 | $4.19M 10-Q · filed 2017-11-13 | $6.76M derived: sum of 4 quarters · filed 2017-11-13 | ||||||||||||||||||
| 2017-06-30 | $1.14M 10-Q · filed 2017-08-14 | $3.21M 10-Q · filed 2017-08-14 | $5.78M derived: sum of 3 quarters · filed 2017-08-14 | $8.96M derived: sum of 4 quarters · filed 2017-11-13 | ||||||||||||||||||
| 2017-03-31 | $2.07M 10-Q · filed 2017-05-09 | $4.64M derived: sum of 2 quarters · filed 2017-05-09 | $7.82M derived: sum of 3 quarters · filed 2017-11-13 | $11.06M derived: sum of 4 quarters · filed 2017-11-13 | ||||||||||||||||||
| 2016-12-31 | $2.56M 10-K · filed 2017-03-31 | $5.75M derived: sum of 2 quarters · filed 2017-11-13 | $8.99M derived: sum of 3 quarters · filed 2017-11-13 | $12.75M 10-K · filed 2017-03-31 | ||||||||||||||||||
| 2016-09-30 | $3.18M 10-Q · filed 2017-11-13 | $6.42M derived: sum of 2 quarters · filed 2017-11-13 | $10.19M 10-Q · filed 2017-11-13 | $15.03M derived: sum of 4 quarters · filed 2017-11-13 | ||||||||||||||||||
| 2016-06-30 | $3.24M 10-Q · filed 2017-08-14 | $7.01M 10-Q · filed 2017-08-14 | $11.85M derived: sum of 3 quarters · filed 2017-08-14 | $17.35M derived: sum of 4 quarters · filed 2017-08-14 | ||||||||||||||||||
| 2016-03-31 | $3.77M 10-Q · filed 2017-05-09 | $8.60M derived: sum of 2 quarters · filed 2017-05-09 | $14.11M derived: sum of 3 quarters · filed 2017-05-09 | $20.56M derived: sum of 4 quarters · filed 2017-05-09 | ||||||||||||||||||
| 2015-12-31 | $4.84M 10-K · filed 2017-03-31 | $10.35M derived: sum of 2 quarters · filed 2017-03-31 | $16.80M derived: sum of 3 quarters · filed 2017-03-31 | $24.12M 10-K · filed 2017-03-31 | ||||||||||||||||||
| 2015-09-30 | $5.51M 10-K · filed 2017-03-31 | $11.96M derived: sum of 2 quarters · filed 2017-03-31 | $19.28M 10-Q · filed 2016-11-09 | $25.05M derived: sum of 4 quarters · filed 2017-03-31 | ||||||||||||||||||
| 2015-06-30 | $6.45M 10-K · filed 2017-03-31 | $13.77M 10-Q · filed 2016-08-09 | $19.54M derived: sum of 3 quarters · filed 2017-03-31 | $25.82M derived: sum of 4 quarters · filed 2017-03-31 | ||||||||||||||||||
| 2015-03-31 | $7.32M 10-K · filed 2017-03-31 | $13.09M derived: sum of 2 quarters · filed 2017-03-31 | $19.37M derived: sum of 3 quarters · filed 2017-03-31 | $26.86M derived: sum of 4 quarters · filed 2017-03-31 | ||||||||||||||||||
| 2014-12-31 | $5.77M 10-K · filed 2016-03-14 | $12.05M derived: sum of 2 quarters · filed 2016-03-14 | $19.54M derived: sum of 3 quarters · filed 2016-03-14 | $27.11M 10-K · filed 2017-03-31 | ||||||||||||||||||
| 2014-09-30 | $6.28M 10-K · filed 2016-03-14 | $6.11M 10-Q · filed 2014-11-10 | $13.77M derived: sum of 2 quarters · filed 2016-03-14 | $21.34M 10-Q · filed 2015-11-09 | $20.88M 10-Q · filed 2014-11-10 | $27.29M derived: sum of 4 quarters · filed 2016-03-14 | $239.05M 10-Q · filed 2014-11-10 | |||||||||||||||
| 2014-06-30 | $7.49M 10-K · filed 2016-03-14 | $7.45M 10-Q · filed 2014-08-11 | $15.06M 10-Q · filed 2015-08-10 | $14.78M 10-Q · filed 2014-08-11 | $21.01M derived: sum of 3 quarters · filed 2016-03-14 | $25.99M derived: sum of 4 quarters · filed 2016-03-14 | $232.95M 10-Q · filed 2014-08-11 | |||||||||||||||
| 2014-03-31 | $7.57M 10-K · filed 2016-03-14 | $7.33M 10-Q · filed 2014-05-12 | $13.52M derived: sum of 2 quarters · filed 2016-03-14 | $18.50M derived: sum of 3 quarters · filed 2016-03-14 | $24.76M derived: sum of 4 quarters · filed 2016-03-14 | $225.50M 10-Q · filed 2014-05-12 | ||||||||||||||||
| 2013-12-31 | $5.95M 10-K · filed 2015-03-16 | $5.78M 10-K · filed 2014-03-14 | $10.93M derived: sum of 2 quarters · filed 2015-03-16 | $17.19M derived: sum of 3 quarters · filed 2015-03-16 | $23.66M 10-K · filed 2016-03-14 | $22.91M 10-K · filed 2014-03-14 | $218.17M 10-K · filed 2014-03-14 | |||||||||||||||
| 2013-09-30 | $4.97M 10-K · filed 2015-03-16 | $4.79M 10-Q · filed 2013-11-07 | $11.24M derived: sum of 2 quarters · filed 2015-03-16 | $17.13M 10-Q · filed 2014-11-10 | $24.27M derived: sum of 4 quarters · filed 2015-03-16 | $212.39M 10-Q · filed 2013-11-07 | ||||||||||||||||
| 2013-06-30 | $6.26M 10-K · filed 2015-03-16 | $6.04M 10-Q · filed 2013-08-07 | $12.35M 10-Q · filed 2014-08-11 | $19.30M derived: sum of 3 quarters · filed 2015-03-16 | $22.43M derived: sum of 4 quarters · filed 2015-03-16 | $207.60M 10-Q · filed 2013-08-07 | ||||||||||||||||
| 2013-03-31 | $6.47M 10-K · filed 2015-03-16 | $6.31M 10-Q · filed 2013-05-10 | $13.04M derived: sum of 2 quarters · filed 2015-03-16 | $16.17M derived: sum of 3 quarters · filed 2015-03-16 | $18.34M derived: sum of 4 quarters · filed 2015-03-16 | $201.57M 10-Q · filed 2013-05-10 | ||||||||||||||||
| 2012-12-31 | $6.57M 10-K · filed 2014-03-14 | $9.70M derived: sum of 2 quarters · filed 2014-03-14 | $11.88M derived: sum of 3 quarters · filed 2014-03-14 | $14.12M 10-K · filed 2015-03-16 | $13.34M 10-K · filed 2013-03-18 | $195.26M 10-K · filed 2013-03-18 | ||||||||||||||||
| 2012-09-30 | $3.13M 10-K · filed 2014-03-14 | $5.31M derived: sum of 2 quarters · filed 2014-03-14 | $6.78M 10-Q · filed 2013-11-07 | $8.48M derived: sum of 4 quarters · filed 2014-03-14 | $188.69M 10-Q · filed 2012-11-14 | |||||||||||||||||
| 2012-06-30 | $2.18M 10-K · filed 2014-03-14 | $3.64M 10-Q · filed 2013-08-07 | $5.34M derived: sum of 3 quarters · filed 2014-03-14 | $8.58M derived: sum of 4 quarters · filed 2014-03-14 | $185.56M 10-Q · filed 2012-08-13 | |||||||||||||||||
| 2012-03-31 | $1.47M 10-K · filed 2014-03-14 | $3.17M derived: sum of 2 quarters · filed 2014-03-14 | $6.40M derived: sum of 3 quarters · filed 2014-03-14 | $8.67M derived: sum of 4 quarters · filed 2014-03-14 | $183.38M 10-Q · filed 2012-05-15 | |||||||||||||||||
| 2011-12-31 | $1.70M 10-K · filed 2013-03-18 | $4.93M derived: sum of 2 quarters · filed 2013-03-18 | $7.20M derived: sum of 3 quarters · filed 2013-03-18 | $8.68M 10-K · filed 2014-03-14 | $181.92M 10-K · filed 2012-03-27 | |||||||||||||||||
| 2011-09-30 | $3.23M 10-K · filed 2013-03-18 | $5.50M derived: sum of 2 quarters · filed 2013-03-18 | $6.98M 10-Q · filed 2012-11-14 | $7.93M derived: sum of 4 quarters · filed 2013-03-18 | $180.21M 10-Q · filed 2011-11-10 | |||||||||||||||||
| 2011-06-30 | $2.27M 10-K · filed 2013-03-18 | $3.75M 10-Q · filed 2012-08-13 | $4.70M derived: sum of 3 quarters · filed 2013-03-18 | $5.44M derived: sum of 4 quarters · filed 2013-03-18 | $176.98M 10-Q · filed 2011-08-09 | |||||||||||||||||
| 2011-03-31 | $1.48M 10-K · filed 2013-03-18 | $2.43M derived: sum of 2 quarters · filed 2013-03-18 | $3.17M derived: sum of 3 quarters · filed 2013-03-18 | $3.93M derived: sum of 4 quarters · filed 2013-03-18 | ||||||||||||||||||
| 2010-12-31 | $954.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $1.69M derived: sum of 2 quarters · filed 2013-03-18 | $2.45M derived: sum of 3 quarters · filed 2013-03-18 | $2.90M 10-K · filed 2013-03-18 | ||||||||||||||||||
| 2010-09-30 | $736.00K 10-Q · filed 2011-11-10 | $1.49M derived: sum of 2 quarters · filed 2011-11-10 | $1.95M 10-Q · filed 2011-11-10 | |||||||||||||||||||
| 2010-06-30 | $756.00K 10-Q · filed 2011-08-09 | $1.21M 10-Q · filed 2011-08-09 | ||||||||||||||||||||
| 2009-12-31 | $23.06M 10-K · filed 2012-03-27 |